Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
IRLAB Therapeutics AB (publ)
IRLAB-ACurrent price
14.15 SEK
+0.2 SEK (+1.43%)
Last closed
13.95 SEK
Company
www.irlab.se
ISIN
SE0012675361
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
742 835 537 SEK
Yield for 12 month
+117.69 %
1Y
3Y
5Y
10Y
15Y
IRLAB-A
IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 research programs for the treatment of neurodegenerative disorders and ageing; IRL1117, a drug candidate developed for once-daily oral treatment for the hallmark symptoms of Parkinson's; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is headquartered in Gothenburg, Sweden. Address: Arvid Wallgrens Backe 20, Gothenburg, Sweden, 413 46
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
440.47 SEKP/E ratio
–Dividend Yield
–Current Year
+5 767 211 SEK
Last Year
+62 096 589 SEK
Current Quarter
+9 172 895 SEK
Last Quarter
+43 449 119 SEK
Current Year
-182 962 280 SEK
Last Year
-112 980 722 SEK
Current Quarter
-37 287 816 SEK
Last Quarter
-9 670 598 SEK
Key Figures IRLAB-A
1 year
3 years
5 years
10 years
EBITDA
-107 611 667 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-38.55 %
PEG Ratio
–
Return On Equity TTM
-121.2 %
Wall Street Target Price
440.47 SEK
Revenue TTM
51 411 293 SEK
Book Value
0.74 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
522.7 %
Dividend Yield
–
Gross Profit TTM
-65 787 684 SEK
Earnings per share
-2.21 SEK
Diluted Eps TTM
-2.21 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-222.69 %
Dividend Analytics IRLAB-A
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IRLAB-A
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
5:1
Payout Ratio
–
Last Split Date
28.05.2019
Dividend Date
–
Stock Valuation IRLAB-A
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
23.3645
Enterprise Value Revenue
13.8543
Price Sales TTM
14.4489
Enterprise Value EBITDA
-3.9299
Price Book MRQ
19.2312
Financials IRLAB-A
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IRLAB-A
For 52 weeks
5.67 SEK
20.52 SEK
50 Day MA
13.1 SEK
Shares Short Prior Month
–
200 Day MA
14.52 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart